Home / Neuroscience
Neuroscience
| 4 min read
In comparative genomic research project using data that is already available in the public domain, researchers from Wayne State University and the Genome Institute of Singapore have identified primate-specific sequences in the human genome. According to the researchers, who summarized their findings in the July 6 online edition of the Proceedings of the National Academy of Sciences, the study has many implications for the field of genomics research.
| 5 min read
Studies in the U.S. and abroad are taking an in-depth look at schizophrenia and bipolar disorder. A study being conducted by U.K. researchers from the MRC Centre for Neuropsychiatric Genetics and Genomics at Cardiff University have revealed thousand of genetic contributions to schizophrenia and bipolar disorder, while in the U.S., a trio of genome-wide studies—collectively the largest to date—have pinpointed a vast array of genetic variations that cumulatively may account for at least one-third of the genetic risk for schizophrenia.
| 3 min read
A team of Utah-based researchers are collaborating on a stem cell therapy to fight amyotrophic lateral sclerosis (ALS), also known as Lou Gehrig’s disease.
| 3 min read
Cellectricon and BioFocus team up to advance high-throughput ion channel drug discovery
| 3 min read
Fast Forward and EMD Serono collaborate on treatments for multiple sclerosis
| 3 min read
Sheffield University team grows stem cells into auditory cells that might one day restore hearing to the deaf
| 3 min read
A decade ago, I was given the above instruction by British colleagues in response to an advertisement of my company’s products that used humor to attract attention.
| 3 min read
ACADIA Pharmaceuticals Inc. and Meiji Seika Kaisha Ltd. announced in April their collaboration to develop and commercialize a novel class of pro-cognitive drugs called PCAPs to treat patients with schizophrenia and related disorders.
| 3 min read
Finding could lead to stem cell therapy for hearing loss
| 3 min read
A collaboration between Imperial College and GSK focused on mRNA suggests signaling problems in the brain may lead to schizophrenia.
| 2 min read
Probing the role that astrocytes play in the progression of neurodegenerative diseases and resulting neuronal cell death, researchers at the University of Wisconsin-Madison (UWM) have discovered that increasing Nrf2 gene activity in astrocytes can completely block neuronal cell death in a mouse model of Parkinson’s disease. According to the researchers, their findings strongly suggest that finding ways to boost the level of Nrf2 activation in the human brain could significantly impact the development and progression of Parkinson’s disease.
| 2 min read
PerkinElmer and IDBS aim to ease high-content screening analysis burdens with Columbus-ActivityBase integration
